Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,215Revenue $M66.2Net Margin (%)-7.6Altman Z-Score50.0
Enterprise Value $M756EPS $-0.1Operating Margin %-22.9Piotroski F-Score6
P/E(ttm)--Beneish M-Score495Pre-tax Margin (%)-7.6Higher ROA y-yY
Price/Book2.710-y EBITDA Growth Rate %-34.7Quick Ratio31.6Cash flow > EarningsY
Price/Sales17.85-y EBITDA Growth Rate %-32.7Current Ratio31.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-1.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-1.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M137ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ACHN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ACHNFirst Eagle Investment 2014-03-31 Sold Out -0.0054%$3.08 - $4.2
($3.51)
$ 8.89153%Sold Out0
ACHNFirst Eagle Investment 2013-12-31 Buy 0.01%$2.43 - $3.46
($2.9)
$ 8.89207%New holding600,000
ACHNGeorge Soros 2012-06-30 Sold Out -0.04%$5.94 - $10.95
($7.34)
$ 8.8921%Sold Out0
ACHNGeorge Soros 2012-03-31 Reduce-0.09%$7.71 - $12.375
($9.57)
$ 8.89-7%Reduce -50.00%250,000
ACHNGeorge Soros 2011-12-31 Add0.16%$4.01 - $8
($6.15)
$ 8.8945%Add 2132.14%500,000
ACHNGeorge Soros 2011-09-30 Buy $4.63 - $8.31
($6.37)
$ 8.8940%New holding22,400
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ACHN is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ACHN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Apelian DavidChief Medical Officer 2015-12-30Sell10,000$10.5-15.33view
Fenton Mary KayCFO 2015-12-28Sell43,500$10.08-11.81view
VITULLO NICOLEDirector 2015-11-11Sell550,000$10.17-12.59view
VITULLO NICOLEDirector 2015-09-25Sell9,310$8.228.15view
VITULLO NICOLEDirector 2015-08-14Sell37,843$7.5118.38view
Fenton Mary KayEVP and CFO 2015-01-23Sell13,125$16-44.44view
Deshpande MilindPresident and CEO 2015-01-21Sell100,000$15-40.73view
RA CAPITAL MANAGEMENT, LLC 2014-09-30Sell1,332,014$10.2-12.84view
RA CAPITAL MANAGEMENT, LLC10% Owner 2014-09-26Sell2,372,915$11.17-20.41view
RA CAPITAL MANAGEMENT, LLC10% Owner 2014-09-23Sell2,595,071$11.29-21.26view

Quarterly/Annual Reports about ACHN:

News about ACHN:

Articles On GuruFocus.com
UBS and JMP Securities Downgrade Achillion Pharmaceuticals Inc.(ACHN) Following Johnson & Johnson (J May 21 2015 
Dycom Industries (DY) Surpasses Estimates; Achillion Pharma (ACHN) Inks Mega-Deal with Janssen May 20 2015 
Gilead Experiencing Bumpy Ride Despite Strong Fundamentals Apr 03 2015 
Achillion Pharmaceuticals Stock Soars Following Successful Mid-Stage Hep C Drug Combo Trial Feb 10 2015 
Hall of Fame/ Hall of Shame: The Best and Worst Recommendations of 2014 Jan 09 2015 
Weekly CEO Sells Highlight: Achillion Pharmaceutical Inc, Protective Life Corp, Host Hotels & Resort Aug 25 2014 
Top 4 Insider Buys of Last Week Jun 10 2013 
Weekly CEO Sells Highlight: Achillion Pharmaceuticals Inc, Monster Beverage Corp, CarMax Inc, and Im Jan 23 2012 
Weekly CEO Sells Highlight: UNH, LRY, ACHN, RPM Jan 16 2012 
Achillion Pharmaceuticals Inc. Reports Operating Results (10-Q) Oct 27 2010 

More From Other Websites
Achillion to Present at the Deutsche Bank 41st Annual Health Care Conference Apr 28 2016
Achillion to Present at the Deutsche Bank 41st Annual Health Care Conference Apr 28 2016
Can the Uptrend Continue for Achillion Pharmaceuticals (ACHN)? Apr 26 2016
ACHILLION PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Apr 08 2016
Five Cheap Healthcare Stocks With Hedge Fund Support Mar 24 2016
Achillion Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACHN-US :... Mar 14 2016
ACHILLION PHARMACEUTICALS INC Financials Mar 03 2016
Achillion Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACHN-US :... Mar 03 2016
Achillion to Present at Two Upcoming Investor Conferences Mar 03 2016
Achillion Pharma upgraded by Robert W. Baird Feb 26 2016
ACHILLION PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 25 2016
ACHILLION PHARMACEUTICALS INC Files SEC form 10-K, Annual Report Feb 25 2016
Peter Kolchinsky Is Betting Big On Achillion Pharmaceuticals, Inc. (ACHN), Wave Life Sciences (WVE)... Feb 25 2016
Achillion beats Street 4Q forecasts Feb 25 2016
Achillion beats Street 4Q forecasts Feb 25 2016
Achillion Reports 2015 Fourth Quarter and Year-End Financial Results Feb 25 2016
Achillion Begins Study on First Complement Factor D Inhibitor Feb 12 2016
Achillion Initiates Phase 1 Study of ACH-4471, First Orally-Administered Small Molecule Complement... Feb 11 2016
Early Briefing on Biotechnology Stocks -- Achillion Pharma, CTI BioPharma, Inovio Pharma, and Keryx... Feb 10 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)